RE:NewsI don't see anything but positives coming from this release. with the green light still green it means that everything that the FDA has requested or directed since mid July is being performed. The mock audit's success is also very important and encouraging. How many small/tiny biotechs have in house manufacturing capability for a therapeutic? Are there any others at this stage with wholly owned in house capability, sub 250 mil market cap. The answer is NO. Telesta and MCNA are so unique, and so far along the commercialization pathway that it is hard for a right thinking person to wrap their head around the valuation, which is probably why most people assume that there is mould in there somewhere behind the walls and never take a second look. No company 120 days from an FDA submission can fly this far under the radar.